The International Pancreas and Islet Transplantation Association aims to serve the pancreas and islet transplant scientific community in providing a forum for the open exchange of knowledge and expertise in order to facilitate the advancement of the clinical practice of pancreas and islet transplantation for the treatment of human diabetes.
These bylaws were amended on February 20, 2013 and
approved by Council on February 28, 2013 and by the membership on April 5th, 2013.
The 2015 tripartite Congress with IXA and CTS in Melbourne, Australia from November 15-19 proved to be an enjoyable and highly successful meeting with a record 629 participants attending.
Prior to the Joint Congress, the IPITA Council held a very productive biennial retreat in nearby Flinders, Victoria on the Mornington Peninsula. After review of the strategic goals set at the 2013 retreat, the group took on a variety of issues critical to the health and future success of the Association.
Finances: The Association's reserves continue to grow; this is in part from a highly successful Key Opinion Leaders meeting in Oxford last year on the future of beta cell replacement. The outlook for the Association remains positive with a projected profit from the Melbourne Congress, a growing membership and ongoing financial review by the Council of annual expenses.
- To promote and encourage research and training relevant to transplantation of insulin producing tissue in the treatment and cure of diabetes mellitus.
- To provide a scientific forum for the exchange and discussion of clinical and experimental results and experiences relevant to transplantation of insulin producing tissue in the treatment and cure of diabetes mellitus.
- To promote and encourage contacts between clinical and experimental researchers from different institutions and from all pertinent disciplines.